Apollo Medical Holdings
- Home ›
- US ›
- Healthcare
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The last earnings update was 3 days ago. More info.
Add to Portfolio Compare Print
AMEH Share Price and Events
7 Day Returns
1 Year Returns
AMEH Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Apollo Medical Holdings (AMEH) | -0.8% | -4.9% | 7.4% | 14.4% | - | - |
| US Healthcare | 3% | -5.1% | 3.1% | 8.2% | 28.3% | 74% |
| US Market | 1.2% | 2.1% | 14.6% | 3% | 39% | 43.5% |
1 Year Return vs Industry and Market
- AMEH outperformed the Healthcare industry which returned 8.2% over the past year.
- AMEH outperformed the Market in United States of America which returned 3% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Apollo Medical Holdings
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Apollo Medical Holdings.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 1 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 7.7% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Unlevered Beta | Simply Wall St/ S&P Global | 0.74 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.736 (1 + (1- 21%) (2.01%)) |
0.831 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.83 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.831 * 5.96%) |
7.68% |
Discounted Cash Flow Calculation for NasdaqCM:AMEH using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Apollo Medical Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 7.68%) |
|
|---|---|---|---|
| 2019 | 10.89 | Est @ -51.84% | 10.11 |
| 2020 | 7.03 | Est @ -35.47% | 6.06 |
| 2021 | 5.34 | Est @ -24.01% | 4.28 |
| 2022 | 4.49 | Est @ -15.99% | 3.34 |
| 2023 | 4.02 | Est @ -10.37% | 2.78 |
| 2024 | 3.76 | Est @ -6.44% | 2.41 |
| 2025 | 3.62 | Est @ -3.69% | 2.16 |
| 2026 | 3.56 | Est @ -1.76% | 1.97 |
| 2027 | 3.54 | Est @ -0.42% | 1.82 |
| 2028 | 3.56 | Est @ 0.53% | 1.70 |
| Present value of next 10 years cash flows | $36.63 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $3.56 × (1 + 2.73%) ÷ (7.68% – 2.73%) |
$73.90 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $73.90 ÷ (1 + 7.68%)10 |
$35.25 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $36.63 + $35.25 |
$71.87 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $71.87 / 35.80 |
$2.01 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $2.01 |
| Current discount | Discount to share price of
$19.03
= -1 x ($19.03 - $2.01) / $2.01 |
-847.8% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Apollo Medical Holdings is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Apollo Medical Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Apollo Medical Holdings's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $0.33 |
| NasdaqCM:AMEH Share Price ** | NasdaqCM (2019-03-20) in USD | $19.03 |
| United States of America Healthcare Industry PE Ratio | Median Figure of 51 Publicly-Listed Healthcare Companies | 21.25x |
| United States of America Market PE Ratio | Median Figure of 3,058 Publicly-Listed Companies | 17.69x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Apollo Medical Holdings.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NasdaqCM:AMEH Share Price ÷ EPS (both in USD) = 19.03 ÷ 0.33 |
57.77x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Medical Holdings is overvalued based on earnings compared to the US Healthcare industry average.
- Apollo Medical Holdings is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Apollo Medical Holdings's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 57.77x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts |
31.7%per year |
| United States of America Healthcare Industry PEG Ratio | Median Figure of 38 Publicly-Listed Healthcare Companies | 1.63x |
| United States of America Market PEG Ratio | Median Figure of 2,103 Publicly-Listed Companies | 1.48x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 57.77x ÷ 31.7% |
1.82x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Medical Holdings is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Apollo Medical Holdings's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $5.22 |
| NasdaqCM:AMEH Share Price * | NasdaqCM (2019-03-20) in USD | $19.03 |
| United States of America Healthcare Industry PB Ratio | Median Figure of 91 Publicly-Listed Healthcare Companies | 2.44x |
| United States of America Market PB Ratio | Median Figure of 5,156 Publicly-Listed Companies | 1.89x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NasdaqCM:AMEH Share Price ÷ Book Value per Share (both in USD) = 19.03 ÷ 5.22 |
3.64x |
* Primary Listing of Apollo Medical Holdings.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Medical Holdings is overvalued based on assets compared to the US Healthcare industry average.
Value checks
We assess Apollo Medical Holdings's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check) Apollo Medical Holdings has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Apollo Medical Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Apollo Medical Holdings's earnings growth is expected to exceed the United States of America market average.
- Apollo Medical Holdings's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NasdaqCM:AMEH Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts | 31.7% |
| NasdaqCM:AMEH Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts | 9.5% |
| United States of America Healthcare Industry Earnings Growth Rate | Market Cap Weighted Average | 13.2% |
| United States of America Healthcare Industry Revenue Growth Rate | Market Cap Weighted Average | 7.3% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 14.3% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (2 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2020-12-31 | 628 | 21 | 1 | |
| 2019-12-31 | 571 | 18 | 1 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 520 | 25 | 11 |
| 2018-09-30 | 508 | 47 | 28 |
| 2018-06-30 | 438 | 41 | 24 |
| 2018-03-31 | 397 | 36 | 24 |
| 2017-12-31 | 356 | 52 | 26 |
| 2017-09-30 | 336 | 44 | 13 |
| 2017-06-30 | 323 | 45 | 11 |
| 2017-03-31 | 317 | 47 | 12 |
| 2016-12-31 | 306 | 22 | 11 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (2 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
All data from Apollo Medical Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2020-12-31 | 0.52 | 0.52 | 0.52 | 1.00 |
| 2019-12-31 | 0.44 | 0.44 | 0.44 | 1.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | 0.33 |
| 2018-09-30 | 0.89 |
| 2018-06-30 | 0.83 |
| 2018-03-31 | 0.86 |
| 2017-12-31 | 1.01 |
| 2017-09-30 | 0.04 |
| 2017-06-30 | 0.03 |
| 2017-03-31 | 0.03 |
| 2016-12-31 | 0.46 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if Apollo Medical Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess Apollo Medical Holdings's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Apollo Medical Holdings has a total score of 4/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Apollo Medical Holdings performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Apollo Medical Holdings has delivered over 20% year on year earnings growth in the past 5 years.
- Apollo Medical Holdings's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Apollo Medical Holdings's 1-year earnings growth is negative, it can't be compared to the US Healthcare industry average.
Earnings and Revenue History
All data from Apollo Medical Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 519.91 | 10.84 | 46.44 | |
| 2018-09-30 | 508.42 | 27.77 | 42.48 | |
| 2018-06-30 | 438.27 | 24.28 | 38.59 | |
| 2018-03-31 | 396.58 | 23.61 | 32.96 | |
| 2017-12-31 | 356.36 | 25.80 | 26.25 | |
| 2017-09-30 | 335.61 | 13.32 | 22.18 | |
| 2017-06-30 | 323.46 | 11.50 | 23.11 | |
| 2017-03-31 | 316.85 | 11.98 | 22.09 | |
| 2016-12-31 | 305.93 | 11.45 | 21.03 | |
| 2015-12-31 | 313.12 | 12.82 | 26.78 | |
| 2014-12-31 | 134.34 | -0.63 | 35.56 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Apollo Medical Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Apollo Medical Holdings used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.
- Apollo Medical Holdings has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Apollo Medical Holdings's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Apollo Medical Holdings has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Apollo Medical Holdings's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Apollo Medical Holdings's finances.
The net worth of a company is the difference between its assets and liabilities.
- Apollo Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Apollo Medical Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is covered by short term assets, assets are 12.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Apollo Medical Holdings Company Filings, last reported 2 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 406.66 | 13.66 | 108.02 |
| 2018-09-30 | 410.27 | 13.80 | 124.36 |
| 2018-06-30 | 370.73 | 13.95 | 103.56 |
| 2018-03-31 | 361.14 | 6.09 | 106.26 |
| 2017-12-31 | 336.31 | 6.25 | 100.89 |
| 2017-09-30 | 178.49 | 0.02 | 78.43 |
| 2017-06-30 | 166.47 | 0.05 | 67.89 |
| 2017-03-31 | 165.61 | 0.07 | 65.32 |
| 2016-12-31 | 250.44 | 0.10 | 56.93 |
| 2015-12-31 | 169.21 | 2.17 | 62.42 |
| 2014-12-31 | 101.55 | 1.53 | 32.14 |
- Apollo Medical Holdings's level of debt (3.4%) compared to net worth is satisfactory (less than 40%).
- Unable to establish if Apollo Medical Holdings's debt level has increased without past 5-year debt data.
- Debt is well covered by operating cash flow (186.7%, greater than 20% of total debt).
- Apollo Medical Holdings earns more interest than it pays, coverage of interest payments is not a concern.
Financial health checks
We assess Apollo Medical Holdings's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Apollo Medical Holdings has a total score of 5/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Apollo Medical Holdings
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Apollo Medical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Apollo Medical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| United States of America Healthcare Industry Average Dividend Yield | Market Cap Weighted Average of 21 Stocks | 1.4% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2004 Stocks | 2.5% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2020-12-31 | ||
| 2019-12-31 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Apollo Medical Holdings has not reported any payouts.
- Unable to verify if Apollo Medical Holdings's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Apollo Medical Holdings's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Apollo Medical Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Apollo Medical Holdings has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| AGE | 46 |
| TENURE AS CEO | 1.3 years |
CEO Bio
Dr. Warren Hosseinion, M.D. has been Co-Chief Executive Officer of Apollo Medical Holdings, Inc. since December 8, 2017. In 2001, Dr. Hosseinion co-founded ApolloMed Hospitalists, a California medical corporation (“ApolloMed Hospitalists” or “AMH”), in Los Angeles. Dr. Hosseinion served as Chief Executive Officer of Apollo Medical Holdings, Inc. since July 3, 2008 until December 11, 2017. He served as an Interim President of Apollo Medical Holdings Inc. since December 9, 2011. Dr. Hosseinion served as a Secretary of Apollo Medical Holdings, Inc. since September 2015 until December 11, 2017. He served as Principal Accounting Officer of Apollo Medical Holdings Inc. Dr. Hosseinion served as an Interim Chairman of the Board of Apollo Medical Holdings, Inc. from December 9, 2011 to February 16, 2012 and has been its Executive Director since July 2008. Dr. Hosseinion holds a B.S. in Biology from University of San Francisco, an M.S in Physiology and Biophysics from Georgetown University and also an Medical Degree from Georgetown University School of Medicine and his residency in internal medicine from the Los Angeles County-University of Southern California Medical Center.
CEO Compensation
- Insufficient data for Warren to compare compensation growth.
- Insufficient data for Warren to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Apollo Medical Holdings management team in years:
- The average tenure for the Apollo Medical Holdings management team is less than 2 years, this suggests a new team.
Management Team
Kenneth Sim
Executive Chairman
Warren Hosseinion
Co-CEO & Director
46
1.3 yrs
Thomas Lam
Co-CEO & Director
69
1.3 yrs
Eric Chin
Chief Financial Officer
0.7 yrs
Hing Ang
Chief Operating Officer
1.3 yrs
Albert Young
Co-Chief Medical Officer
1.3 yrs
Adrian Vazquez
Co-Chief Medical Officer
48
Board of Directors Tenure
Average tenure and age of the Apollo Medical Holdings board of directors in years:
- The average tenure for the Apollo Medical Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors
Kenneth Sim
Executive Chairman
1.3 yrs
Warren Hosseinion
Co-CEO & Director
46
10.7 yrs
Thomas Lam
Co-CEO & Director
69
1.3 yrs
Mark Fawcett
Director
51
Michael Eng
Director
1.3 yrs
Dave Schmidt
Director
70
1.3 yrs
Mitchell Kitayama
Director
1.3 yrs
Li Yu
Director
1.3 yrs
Ernest Bates
Director
81
0.8 yrs
Linda Marsh
Director
0.2 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 01. Dec 18 | Sell | Warren Hosseinion | Individual | 28. Nov 18 | 28. Nov 18 | -35,000 | $16.60 | $-581,000 | ||
| 29. Nov 18 | Sell | Warren Hosseinion | Individual | 26. Nov 18 | 27. Nov 18 | -50,000 | $17.91 | $-877,500 | ||
| 27. Nov 18 | Sell | Warren Hosseinion | Individual | 21. Nov 18 | 23. Nov 18 | -50,000 | $17.07 | $-827,700 | ||
| 22. Nov 18 | Sell | Warren Hosseinion | Individual | 19. Nov 18 | 20. Nov 18 | -40,000 | $18.97 | $-731,000 | ||
| 21. Nov 18 | Sell | Adrian Vazquez | Individual | 19. Nov 18 | 21. Nov 18 | -221,597 | $18.56 | $-3,889,749 | ||
| 11. Sep 18 | Sell | Adrian Vazquez | Individual | 07. Sep 18 | 10. Sep 18 | -33,574 | $16.01 | $-512,089 | ||
| 31. Aug 18 | Sell | Warren Hosseinion | Individual | 29. Aug 18 | 30. Aug 18 | -22,900 | $16.03 | $-364,954 | ||
| 29. Aug 18 | Sell | Adrian Vazquez | Individual | 27. Aug 18 | 27. Aug 18 | -25,000 | $17.35 | $-433,750 | ||
| 29. Aug 18 | Sell | Warren Hosseinion | Individual | 27. Aug 18 | 28. Aug 18 | -30,000 | $17.35 | $-510,000 | ||
| 27. Aug 18 | Sell | Warren Hosseinion | Individual | 23. Aug 18 | 24. Aug 18 | -33,000 | $16.47 | $-534,510 | ||
| 24. Aug 18 | Sell | Gary Augusta | Individual | 17. Aug 18 | 17. Aug 18 | -12,948 | $18.71 | $-242,218 | ||
| 23. Aug 18 | Sell | Warren Hosseinion | Individual | 21. Aug 18 | 22. Aug 18 | -30,000 | $16.73 | $-495,750 | ||
| 21. Aug 18 | Sell | Warren Hosseinion | Individual | 17. Aug 18 | 20. Aug 18 | -22,000 | $18.51 | $-398,100 | ||
| 15. Jun 18 | Sell | Warren Hosseinion | Individual | 14. Jun 18 | 14. Jun 18 | -20,000 | $16.35 | $-327,000 | ||
| 14. Jun 18 | Sell | Warren Hosseinion | Individual | 12. Jun 18 | 13. Jun 18 | -28,000 | $15.77 | $-437,270 | ||
| 12. Jun 18 | Sell | Warren Hosseinion | Individual | 08. Jun 18 | 11. Jun 18 | -20,000 | $15.44 | $-303,120 | ||
| 08. Jun 18 | Sell | Warren Hosseinion | Individual | 06. Jun 18 | 07. Jun 18 | -28,411 | $14.70 | $-410,374 | ||
| 06. Jun 18 | Sell | Warren Hosseinion | Individual | 04. Jun 18 | 05. Jun 18 | -27,752 | $14.85 | $-411,146 | ||
| 04. Jun 18 | Sell | Warren Hosseinion | Individual | 31. May 18 | 01. Jun 18 | -21,352 | $14.37 | $-299,816 | ||
| 31. May 18 | Sell | Warren Hosseinion | Individual | 29. May 18 | 30. May 18 | -11,752 | $13.52 | $-157,477 | ||
| 29. May 18 | Sell | Warren Hosseinion | Individual | 24. May 18 | 25. May 18 | -11,752 | $14.19 | $-163,882 | ||
| 24. May 18 | Sell | Warren Hosseinion | Individual | 22. May 18 | 23. May 18 | -11,752 | $15.39 | $-176,750 | ||
| 22. May 18 | Sell | Warren Hosseinion | Individual | 18. May 18 | 21. May 18 | -11,752 | $15.90 | $-185,447 | ||
Management checks
We assess Apollo Medical Holdings's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Apollo Medical Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Should You Be Holding Apollo Medical Holdings, Inc. (NASDAQ:AMEH)?
Building up an investment case requires looking at a stock holistically. … Today I've chosen to put the spotlight on Apollo Medical Holdings, Inc. … In the following section, I expand a bit more on these key aspects
Simply Wall St - – Full articleHow Much Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Do Insiders Own?
Every investor in Apollo Medical Holdings, Inc. … I generally like to see some degree of insider ownership, even if only a little. … With a market capitalization of US$645m, Apollo Medical Holdings is a small cap stock, so it might not be well known by many institutional investors.
Simply Wall St - – Full articleApollo Medical Holdings, Inc. (NASDAQ:AMEH) Earns A Nice Return On Capital Employed
To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Understanding Return On Capital Employed (ROCE). … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleCan Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Maintain Its Strong Returns?
With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … To keep the lesson grounded in practicality, we'll use ROE to better understand Apollo Medical Holdings, Inc. … Over the last twelve months Apollo Medical Holdings has recorded a ROE of 20%.
Simply Wall St - – Full articleHow Many Insiders Sold Apollo Medical Holdings Inc (NASDAQ:AMEH) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Apollo Medical Holdings Inc (NASDAQ:AMEH). … Apollo Medical Holdings Insider Transactions Over The Last Year. … All up, insiders sold more shares in Apollo Medical Holdings than they bought, over the last year
Simply Wall St - – Full articleWhy Apollo Medical Holdings Inc (NASDAQ:AMEH) Could Have A Place In Your Portfolio
As an investor, I look for investments which does not compromise one fundamental factor for another. … By this I mean, I look at stocks holistically, from their financial health to their future outlook. … is a company with great financial health as well as a.
Simply Wall St - – Full articleHealthcare Industry Trends And Its Impact On Apollo Medical Holdings Inc (NASDAQ:AMEH)
which faces key trends such as rising demand fuelled by an aging population and the growing prevalence of chronic diseases … healthcare providers are faced with particularly difficult and interdependent challenges … A focus towards more collaborative and data-driven care models, which address behavioural and physical health of chronic illness or aging patients, may help improve patient outcomes and lowered costs.
Simply Wall St - – Full articleWho Just Sold Their Shares In Apollo Medical Holdings Inc (NASDAQ:AMEH)?
Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. … Apollo Medical Holdings is one of United States’s. … some insider selling over the past three months, with insiders divesting from.
Simply Wall St - – Full articleApollo Medical Holdings Inc (NASDAQ:AMEH): Can It Deliver A Superior ROE To The Industry?
Apollo Medical Holdings Inc (NASDAQ:AMEH) performed in line with its healthcare services industry on the basis of its ROE – producing a return of 13.79% relative to the peer average of 13.81% over the past 12 months. … But what is more interesting is whether AMEH can sustain or improve on this level of return. … Metrics such as financial leverage can impact the level of ROE which in turn can affect the sustainability of AMEH's returns
Simply Wall St - – Full articleWhat Investors Should Know About Apollo Medical Holdings Inc's (NASDAQ:AMEH) Financial Strength
Investors are always looking for growth in small-cap stocks like Apollo Medical Holdings Inc (NASDAQ:AMEH), with a market cap of US$811.35m. … However, an important fact which most ignore is: how financially healthy is the business?
Simply Wall St - – Full articleCompany Info
Description
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Details
| Name: | Apollo Medical Holdings, Inc. |
| AMEH | |
| Exchange: | NasdaqCM |
| Founded: | 1994 |
| $681,255,978 | |
| 35,799,053 | |
| Website: | http://www.apollomed.net |
| Address: |
Apollo Medical Holdings, Inc. 1668 South Garfield Avenue, 2nd Floor, Alhambra, California, 91801, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NasdaqCM | AMEH | Common Stock | Nasdaq Capital Market | US | USD | 11. Dec 2017 |
Number of employees
Current staff
Industry
| Health Care Services | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/03/21 01:11 |
| End of day share price update: | 2019/03/20 00:00 |
| Last estimates confirmation: | 2019/03/18 |
| Last earnings filing: | 2019/03/18 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
